PRECISION BIOSCIENCES INC — Director's Dealing 2023

Apr 13, 2023

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: PRECISION BIOSCIENCES INC (DTIL)
CIK: 0001357874
Period of Report: 2023-04-11

Reporting Person: Buehler Kevin (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2023-04-11	Common Stock	M	5701	—	Acquired	5701	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2023-04-11	Restricted Stock Units	$	M	5701	Disposed		Common Stock (5701)	Direct

Footnotes

F1: Represents the vesting and settlement of Restricted Stock Units ("RSUs") on April 11, 2023

F2: Each RSU represents a contingent right to receive one share of the Issuer's Common Stock.

F3: On April 11, 2022 the Issuer granted RSUs to the Reporting Person in connection with the Reporting Person's service as Chair of the Board. The RSUs vested in full on April 11, 2023.